Antimycobacterial and cytotoxicity activities of free and liposome-encapsulated 3-(4'-bromo[1,1'-biphenyl-4-yl)-3-(4-bromo-phenyl)-N,N-dimethyl-2-propen-1-amine

AUTOR(ES)

Souza, Ana O. de, Silva, Célio L., Durán, Nelson, Andrade-Santana, Maria H.

FONTE

Química Nova

DATA DE PUBLICAÇÃO

2010

RESUMO

The antimycobacterial activity of 3-(4'-bromo[1,1'-biphenyl-4-yl)-3-(4-bromo-phenyl)-N,N-dimethyl-2-propen-1-amine (BBAP), free or incorporated in preformed liposomes, on extracellular M. tuberculosis H37Rv was 8 and 25 μM (MIC), respectively. Extracellular antimycobacterial activity was not significantly improved by entrapment of BBAP in liposomes, but there was a 6.1-fold reduction of BBAP cytotoxicity on J774 macrophages. Liposomal BBAP or its free form showed IC50 values of 165 and 27 μM, resulting in a selectivity index (SI=IC50/MIC) of 3.4 and 6.6, respectively. Free BBAP in concentrations from 10 to 80 μM were quite effective in eliminating intracellular M. tuberculosis while liposomal formulation was less effective at these concentrations.

Documentos Relacionados

• Antichagasicos 3-[4 -bromo-(1,1 -bifenil)-4-il]-3-(4-x-fenil)-N,N-dimetil-2-propen-1-amina
• In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
• Distribution of liposome-encapsulated antimony in dogs
• Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.
• Free 2-propen-1-amine derivative and inclusion complexes with beta-cyclodextrin: scanning electron microscopy, dissolution, cytotoxicity and antimycobacterial activity